782 related articles for article (PubMed ID: 28893303)
1. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
Tang S; Xiang C; Yang Q
Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
[TBL] [Abstract][Full Text] [Related]
5. Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI.
Savaridas SL; Vinnicombe SJ; Warwick V; Evans A
Br J Radiol; 2023 Aug; 96(1148):20220921. PubMed ID: 37399083
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced spectral mammography in patients with MRI contraindications.
Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer.
Steinhof-Radwańska K; Grażyńska A; Lorek A; Gisterek I; Barczyk-Gutowska A; Bobola A; Okas K; Lelek Z; Morawska I; Potoczny J; Niemiec P; Szyluk K
Curr Oncol; 2021 Sep; 28(5):3448-3462. PubMed ID: 34590596
[TBL] [Abstract][Full Text] [Related]
10. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
[TBL] [Abstract][Full Text] [Related]
13. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
[TBL] [Abstract][Full Text] [Related]
14. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
An YY; Kim SH; Kang BJ
World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
[TBL] [Abstract][Full Text] [Related]
15. MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
Goorts B; Dreuning KMA; Houwers JB; Kooreman LFS; Boerma EG; Mann RM; Lobbes MBI; Smidt ML
Breast Cancer Res; 2018 Apr; 20(1):34. PubMed ID: 29669584
[TBL] [Abstract][Full Text] [Related]
16. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
[TBL] [Abstract][Full Text] [Related]
17. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
[TBL] [Abstract][Full Text] [Related]
18. Can unenhanced MRI of the breast replace contrast-enhanced MRI in assessing response to neoadjuvant chemotherapy?
Cavallo Marincola B; Telesca M; Zaccagna F; Riemer F; Anzidei M; Catalano C; Pediconi F
Acta Radiol; 2019 Jan; 60(1):35-44. PubMed ID: 29742918
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
[TBL] [Abstract][Full Text] [Related]
20. Comparison between breast MRI and contrast-enhanced spectral mammography.
Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
